NFE2L2 and obesity due to melanocortin 4 receptor deficiency: Since Nrf2 activation inhibits adipocyte differentiation, the benefits of an Nrf2 activator administration on HFD-induced obesity seems to be through the direct inhibition of adipocyte differentiation [140,141].